Viome Leadership

Naveen K. Jain (born September 6, 1959) is a business executive, entrepreneur, and the founder and former CEO of InfoSpace. InfoSpace briefly became one of the largest internet companies in the American Northwest, before the crash of the dot-com bubble and a series of lawsuits involving Jain. In 2010 Jain co-founded Moon Express where he is the Executive Chairman, and in 2016 founded Viome, where he is the CEO.

Besides providing scientific leadership, I focus on product development, conversion of RUO assays into CLIA LDTs, and clinical research. I am also an Adjunct Professor at University of New Mexico (UNM) and New Mexico Tech (NMT). Before founding Viome, I worked for 12 years as a scientist at Los Alamos National Laboratory (LANL), where I was the leader of the Applied Genomics team. My team's research focused on developing and applying modern genomics to the areas of gut microbiomes, host-pathogen interactions, microbial inter-species interactions, pathogen detection, cancer biology, toxicology, infectious diseases, antibiotic resistance, forensics, etc. I also helped set up several turn-key genome centers in Africa and Asia, and provided complete staff training in laboratory methods and bioinformatic analyses.

John Blanchard is a Chief Operating Officer at Viome.

Naveen K. Jain (born September 6, 1959) is a business executive, entrepreneur, and the founder and former CEO of InfoSpace. InfoSpace briefly became one of the largest internet companies in the American Northwest, before the crash of the dot-com bubble and a series of lawsuits involving Jain. In 2010 Jain co-founded Moon Express where he is the Executive Chairman, and in 2016 founded Viome, where he is the CEO.

Besides providing scientific leadership, I focus on product development, conversion of RUO assays into CLIA LDTs, and clinical research. I am also an Adjunct Professor at University of New Mexico (UNM) and New Mexico Tech (NMT). Before founding Viome, I worked for 12 years as a scientist at Los Alamos National Laboratory (LANL), where I was the leader of the Applied Genomics team. My team's research focused on developing and applying modern genomics to the areas of gut microbiomes, host-pathogen interactions, microbial inter-species interactions, pathogen detection, cancer biology, toxicology, infectious diseases, antibiotic resistance, forensics, etc. I also helped set up several turn-key genome centers in Africa and Asia, and provided complete staff training in laboratory methods and bioinformatic analyses.